Cited by 175Medication Adherence and CompliancePharmaceutical Practices and Patient OutcomesPharmacy and Medical Practices

Prevalence of and factors associated with primary medication non‐adherence in chronic disease: A systematic review and meta‐analysis

Open access
Cheen, McVin Hua Heng, Tan, Yan Zhi, Oh, Ling Fen, Wee, Hwee Lin, Thumboo, Julian·2019·International Journal of Clinical Practice

Abstract

BACKGROUND: Primary medication non-adherence (PMN), defined as failure to obtain newly prescribed medications, results in adverse clinical and economic outcomes. We aimed to (a) assess the prevalence of PMN in six common chronic diseases: asthma and/ or chronic obstructive pulmonary disease, depression, diabetes mellitus, hyperlipidaemia, hypertension and osteoporosis; (b) identify and categorise factors associated with PMN; (c) explore characteristics that contributed to heterogeneity between studies. METHODS: We performed a systematic search in MEDLINE, Embase, Cochrane Library, CINAHL and PsycINFO. Studies published in English between January 2008 and August 2018 assessing PMN in subjects aged ≥18 years were included. We used the Cochrane risk of bias tool, Newcastle-Ottawa Scale and National Heart, Lung and Blood Institute Quality Assessment Tool to assess the quality of randomised controlled trials, cohort and cross-sectional studies, respectively. Findings were reported using the PRISMA checklist. PMN rates were pooled using a random effects model. We summarised factors associated with PMN descriptively. Subgroup analysis was performed to explore sources of heterogeneity. RESULTS: We screened 3083 articles and included 33 (5 randomised controlled trials, 26 cohort and 2 cross-sectional studies, n = 539 156), of which 31 (n = 519 971) were used in meta-analysis. The pooled PMN rate was 17% (95% CI: 15%-20%). Pooled PMN rates were highest in osteoporosis (25%, 95% CI: 7%-44%) and hyperlipidaemia (25%, 95% CI: 18%-32%) and lowest in diabetes mellitus (10%, 95% CI: 7%-12%). Factors commonly associated with PMN include younger age, number of concurrent medications, practitioner specialty and higher co-payment. Type of chronic disease, age, study setting and PMN definition contributed to heterogeneity between studies (all P < 0.001). CONCLUSION: Primary medication non-adherence is common among patients with chronic diseases and more needs to be done to address this issue in order to improve patient outcomes. Future PMN studies could benefit from greater standardisation to enhance comparability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ijcp.13350

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Adams A, Hubbard T, Stolpe S, Cranston L. Health Affairs Blog. The First fill factor: A threat to outcomes, quality, and pay- ment goals. 2015. https://www.healthaffairs.org/do/10.1377/ hblog20150401.046033/full/. Accessed September 19, 2018. · DOI
  2. Lee JS, Joyce G, McCombs J. Outcomes associated with primary and secondary nonadherence to cholesterol medications. Am J Pharm Benefits. 2016;8:54-60.
  3. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Chapter 8: Assessing risk of bias in included studies. 2011. http://handbook-5-1.cochrane.org/chap- ter_8/8_assessing_risk_of_bias_in_included_studies.htm. Accessed September 19, 2018.

Cited by

Sorted by citations

Authors
Cheen, M. H. H., Tan, Y. Z., Oh, L. F., Wee, H. L., & Thumboo, J.
Affiliations
  • Singapore General Hospital (SG)
  • National University of Singapore (SG)
Corresponding author
Cheen, McVin Hua Heng
Venue
International Journal of Clinical Practice
Publisher
Wiley
Published
2019-05-15
Volume
73
Issue
6
Pages
e13350
ISSN
  • 1368-5031 (ISSN-L)
  • 1742-1241
OpenAlex
W2930999806
Cited by
175
References
53
Citations by year
2026: 10 · 2025: 30 · 2024: 39 · 2023: 30 · 2022: 28 · 2021: 25 · 2020: 11 · 2019: 2
FWCI
4.19
Type
journal article
Language
en
Open access
Locations
  • International Journal of Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
Keywords
chronic disease, prevalence, risk factors, asthma, chronic obstructive pulmonary disease, depression, diabetes mellitus, hyperlipidemia, hypertension, osteoporosis, polypharmacy, copayments
MeSH terms
Assessment of Medication Adherence, Chronic Disease, Humans, Models, Statistical, Drug Monitoring, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review